Qingxin Kaiqiao Fang decreases Tau hyperphosphorylation in Alzheimer's disease via the PI3K/Akt/GSK3β pathway in vitro and in vivo
Author:
Funder
National Natural Science Foundation of China
Natural Science Foundation of Zhejiang Province
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference57 articles.
1. Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology;Ashton;Acta Neuropathol.,2021
2. Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies;Avrahami;J. Biol. Chem.,2013
3. Class I PI3K biology;Aytenfisu;Curr. Top. Microbiol. Immunol.,2022
4. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease;Barthélemy;Nat. Med.,2020
5. Assessment of headache characteristics, impact, and managing techniques among pharmacy and nursing undergraduates-an observational study;Bashatah;Medicina,2023
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Norboldine improves cognitive impairment and pathological features in Alzheimer's disease by activating AMPK/GSK3β/Nrf2 signaling pathway;Journal of Ethnopharmacology;2024-10
2. Regulating Lars2 in mitochondria: A potential Alzheimer's therapy by inhibiting tau phosphorylation;Neurotherapeutics;2024-07
3. Esketamine induces tripartite motif-containing protein 24 to improve cognitive dysfunction in Alzheimer’s disease;Neuroscience Letters;2024-06
4. N1F(Improved-Nephropathy 1 Formula) Ameliorates Renal Interstitial Fibrosis via Inhibiting Extracellular Matrix Deposition and Regulating the FGF23/P38MAPK/Wnt Pathway;Cell Biochemistry and Biophysics;2024-05-09
5. Targeting PI3K/Akt in Cerebral Ischemia Reperfusion Injury Alleviation: From Signaling Networks to Targeted Therapy;Molecular Neurobiology;2024-03-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3